経口ペプチド療法のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Oral Peptide Therapy Market Insights, Forecast to 2028

• レポートコード：QY2207E10446 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の経口ペプチド療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に経口ペプチド療法の世界市場のxxx％を占める「リナクロチド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の経口ペプチド療法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの経口ペプチド療法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの経口ペプチド療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 経口ペプチド療法のグローバル主要メーカーには、Allergan、Novo Nordisk、Synergy Pharmaceuticals （Salix）、Novartis、Chiasmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 経口ペプチド療法市場は、種類と用途によって区分されます。世界の経口ペプチド療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 リナクロチド、インスリン、プレカナチド、シクロスポリン、オクトレオチド 【用途別セグメント】 病院、小売薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 経口ペプチド療法製品概要 - 種類別市場（リナクロチド、インスリン、プレカナチド、シクロスポリン、オクトレオチド） - 用途別市場（病院、小売薬局） - 調査の目的 ・エグゼクティブサマリー - 世界の経口ペプチド療法販売量予測2017-2028 - 世界の経口ペプチド療法売上予測2017-2028 - 経口ペプチド療法の地域別販売量 - 経口ペプチド療法の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別経口ペプチド療法販売量 - 主要メーカー別経口ペプチド療法売上 - 主要メーカー別経口ペプチド療法価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（リナクロチド、インスリン、プレカナチド、シクロスポリン、オクトレオチド） - 経口ペプチド療法の種類別販売量 - 経口ペプチド療法の種類別売上 - 経口ペプチド療法の種類別価格 ・用途別市場規模（病院、小売薬局） - 経口ペプチド療法の用途別販売量 - 経口ペプチド療法の用途別売上 - 経口ペプチド療法の用途別価格 ・北米市場 - 北米の経口ペプチド療法市場規模（種類別、用途別） - 主要国別の経口ペプチド療法市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの経口ペプチド療法市場規模（種類別、用途別） - 主要国別の経口ペプチド療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の経口ペプチド療法市場規模（種類別、用途別） - 主要国別の経口ペプチド療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の経口ペプチド療法市場規模（種類別、用途別） - 主要国別の経口ペプチド療法市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの経口ペプチド療法市場規模（種類別、用途別） - 主要国別の経口ペプチド療法市場規模（トルコ、サウジアラビア） ・企業情報 Allergan、Novo Nordisk、Synergy Pharmaceuticals （Salix）、Novartis、Chiasma ・産業チェーン及び販売チャネル分析 - 経口ペプチド療法の産業チェーン分析 - 経口ペプチド療法の原材料 - 経口ペプチド療法の生産プロセス - 経口ペプチド療法の販売及びマーケティング - 経口ペプチド療法の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 経口ペプチド療法の産業動向 - 経口ペプチド療法のマーケットドライバー - 経口ペプチド療法の課題 - 経口ペプチド療法の阻害要因 ・主な調査結果

The drugs give through oral.
Market Analysis and Insights: Global Oral Peptide Therapy Market
Due to the COVID-19 pandemic, the global Oral Peptide Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Linaclotide accounting for % of the Oral Peptide Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Oral Peptide Therapy market size is valued at US$ million in 2021, while the US and Europe Oral Peptide Therapy are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral Peptide Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Oral Peptide Therapy include Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis and Chiasma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Oral Peptide Therapy Scope and Segment
Oral Peptide Therapy market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Oral Peptide Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Segment by Application
Hospital
Retail Pharmacy
By Company
Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Oral Peptide Therapy Product Introduction
1.2 Market by Type
1.2.1 Global Oral Peptide Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Market by Application
1.3.1 Global Oral Peptide Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Peptide Therapy Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Peptide Therapy Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Peptide Therapy Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Peptide Therapy Sales by Region
2.4.1 Global Oral Peptide Therapy Sales by Region (2017-2022)
2.4.2 Global Sales Oral Peptide Therapy by Region (2023-2028)
2.5 Global Oral Peptide Therapy Revenue by Region
2.5.1 Global Oral Peptide Therapy Revenue by Region (2017-2022)
2.5.2 Global Oral Peptide Therapy Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Peptide Therapy Sales by Manufacturers
3.1.1 Global Top Oral Peptide Therapy Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Peptide Therapy Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Peptide Therapy in 2021
3.2 Global Oral Peptide Therapy Revenue by Manufacturers
3.2.1 Global Oral Peptide Therapy Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Peptide Therapy Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Peptide Therapy Revenue in 2021
3.3 Global Oral Peptide Therapy Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Peptide Therapy Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Peptide Therapy Sales by Type
4.1.1 Global Oral Peptide Therapy Historical Sales by Type (2017-2022)
4.1.2 Global Oral Peptide Therapy Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Peptide Therapy Sales Market Share by Type (2017-2028)
4.2 Global Oral Peptide Therapy Revenue by Type
4.2.1 Global Oral Peptide Therapy Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Peptide Therapy Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
4.3 Global Oral Peptide Therapy Price by Type
4.3.1 Global Oral Peptide Therapy Price by Type (2017-2022)
4.3.2 Global Oral Peptide Therapy Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Peptide Therapy Sales by Application
5.1.1 Global Oral Peptide Therapy Historical Sales by Application (2017-2022)
5.1.2 Global Oral Peptide Therapy Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Peptide Therapy Sales Market Share by Application (2017-2028)
5.2 Global Oral Peptide Therapy Revenue by Application
5.2.1 Global Oral Peptide Therapy Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Peptide Therapy Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
5.3 Global Oral Peptide Therapy Price by Application
5.3.1 Global Oral Peptide Therapy Price by Application (2017-2022)
5.3.2 Global Oral Peptide Therapy Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Peptide Therapy Market Size by Type
6.1.1 North America Oral Peptide Therapy Sales by Type (2017-2028)
6.1.2 North America Oral Peptide Therapy Revenue by Type (2017-2028)
6.2 North America Oral Peptide Therapy Market Size by Application
6.2.1 North America Oral Peptide Therapy Sales by Application (2017-2028)
6.2.2 North America Oral Peptide Therapy Revenue by Application (2017-2028)
6.3 North America Oral Peptide Therapy Market Size by Country
6.3.1 North America Oral Peptide Therapy Sales by Country (2017-2028)
6.3.2 North America Oral Peptide Therapy Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oral Peptide Therapy Market Size by Type
7.1.1 Europe Oral Peptide Therapy Sales by Type (2017-2028)
7.1.2 Europe Oral Peptide Therapy Revenue by Type (2017-2028)
7.2 Europe Oral Peptide Therapy Market Size by Application
7.2.1 Europe Oral Peptide Therapy Sales by Application (2017-2028)
7.2.2 Europe Oral Peptide Therapy Revenue by Application (2017-2028)
7.3 Europe Oral Peptide Therapy Market Size by Country
7.3.1 Europe Oral Peptide Therapy Sales by Country (2017-2028)
7.3.2 Europe Oral Peptide Therapy Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Peptide Therapy Market Size by Type
8.1.1 Asia Pacific Oral Peptide Therapy Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Peptide Therapy Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Peptide Therapy Market Size by Application
8.2.1 Asia Pacific Oral Peptide Therapy Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Peptide Therapy Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Peptide Therapy Market Size by Region
8.3.1 Asia Pacific Oral Peptide Therapy Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Peptide Therapy Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oral Peptide Therapy Market Size by Type
9.1.1 Latin America Oral Peptide Therapy Sales by Type (2017-2028)
9.1.2 Latin America Oral Peptide Therapy Revenue by Type (2017-2028)
9.2 Latin America Oral Peptide Therapy Market Size by Application
9.2.1 Latin America Oral Peptide Therapy Sales by Application (2017-2028)
9.2.2 Latin America Oral Peptide Therapy Revenue by Application (2017-2028)
9.3 Latin America Oral Peptide Therapy Market Size by Country
9.3.1 Latin America Oral Peptide Therapy Sales by Country (2017-2028)
9.3.2 Latin America Oral Peptide Therapy Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Oral Peptide Therapy Market Size by Type
10.1.1 Middle East and Africa Oral Peptide Therapy Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Peptide Therapy Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Peptide Therapy Market Size by Application
10.2.1 Middle East and Africa Oral Peptide Therapy Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Peptide Therapy Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Peptide Therapy Market Size by Country
10.3.1 Middle East and Africa Oral Peptide Therapy Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Peptide Therapy Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Overview
11.2.3 Novo Nordisk Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novo Nordisk Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novo Nordisk Recent Developments
11.3 Synergy Pharmaceuticals （Salix）
11.3.1 Synergy Pharmaceuticals （Salix） Corporation Information
11.3.2 Synergy Pharmaceuticals （Salix） Overview
11.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Synergy Pharmaceuticals （Salix） Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Chiasma
11.5.1 Chiasma Corporation Information
11.5.2 Chiasma Overview
11.5.3 Chiasma Oral Peptide Therapy Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Chiasma Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chiasma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Peptide Therapy Industry Chain Analysis
12.2 Oral Peptide Therapy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Peptide Therapy Production Mode & Process
12.4 Oral Peptide Therapy Sales and Marketing
12.4.1 Oral Peptide Therapy Sales Channels
12.4.2 Oral Peptide Therapy Distributors
12.5 Oral Peptide Therapy Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Peptide Therapy Industry Trends
13.2 Oral Peptide Therapy Market Drivers
13.3 Oral Peptide Therapy Market Challenges
13.4 Oral Peptide Therapy Market Restraints
14 Key Findings in The Global Oral Peptide Therapy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Oral Peptide Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Linaclotide
Table 3. Major Manufacturers of Insulin
Table 4. Major Manufacturers of Plecanatide
Table 5. Major Manufacturers of Cyclosporine
Table 6. Major Manufacturers of Octreotide
Table 7. Global Oral Peptide Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Oral Peptide Therapy Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Oral Peptide Therapy Sales by Region (2017-2022) & (Units)
Table 10. Global Oral Peptide Therapy Sales Market Share by Region (2017-2022)
Table 11. Global Oral Peptide Therapy Sales by Region (2023-2028) & (Units)
Table 12. Global Oral Peptide Therapy Sales Market Share by Region (2023-2028)
Table 13. Global Oral Peptide Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Oral Peptide Therapy Revenue Market Share by Region (2017-2022)
Table 15. Global Oral Peptide Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Oral Peptide Therapy Revenue Market Share by Region (2023-2028)
Table 17. Global Oral Peptide Therapy Sales by Manufacturers (2017-2022) & (Units)
Table 18. Global Oral Peptide Therapy Sales Share by Manufacturers (2017-2022)
Table 19. Global Oral Peptide Therapy Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Oral Peptide Therapy Revenue Share by Manufacturers (2017-2022)
Table 21. Oral Peptide Therapy Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Oral Peptide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Oral Peptide Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Therapy as of 2021)
Table 24. Oral Peptide Therapy Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Oral Peptide Therapy Product Offered
Table 26. Date of Manufacturers Enter into Oral Peptide Therapy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Oral Peptide Therapy Sales by Type (2017-2022) & (Units)
Table 29. Global Oral Peptide Therapy Sales by Type (2023-2028) & (Units)
Table 30. Global Oral Peptide Therapy Sales Share by Type (2017-2022)
Table 31. Global Oral Peptide Therapy Sales Share by Type (2023-2028)
Table 32. Global Oral Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Oral Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Oral Peptide Therapy Revenue Share by Type (2017-2022)
Table 35. Global Oral Peptide Therapy Revenue Share by Type (2023-2028)
Table 36. Oral Peptide Therapy Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Oral Peptide Therapy Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Oral Peptide Therapy Sales by Application (2017-2022) & (Units)
Table 39. Global Oral Peptide Therapy Sales by Application (2023-2028) & (Units)
Table 40. Global Oral Peptide Therapy Sales Share by Application (2017-2022)
Table 41. Global Oral Peptide Therapy Sales Share by Application (2023-2028)
Table 42. Global Oral Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Oral Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Oral Peptide Therapy Revenue Share by Application (2017-2022)
Table 45. Global Oral Peptide Therapy Revenue Share by Application (2023-2028)
Table 46. Oral Peptide Therapy Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Oral Peptide Therapy Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Oral Peptide Therapy Sales by Type (2017-2022) & (Units)
Table 49. North America Oral Peptide Therapy Sales by Type (2023-2028) & (Units)
Table 50. North America Oral Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Oral Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Oral Peptide Therapy Sales by Application (2017-2022) & (Units)
Table 53. North America Oral Peptide Therapy Sales by Application (2023-2028) & (Units)
Table 54. North America Oral Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Oral Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 57. North America Oral Peptide Therapy Sales by Country (2023-2028) & (Units)
Table 58. North America Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Oral Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Oral Peptide Therapy Sales by Type (2017-2022) & (Units)
Table 61. Europe Oral Peptide Therapy Sales by Type (2023-2028) & (Units)
Table 62. Europe Oral Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Oral Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Oral Peptide Therapy Sales by Application (2017-2022) & (Units)
Table 65. Europe Oral Peptide Therapy Sales by Application (2023-2028) & (Units)
Table 66. Europe Oral Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Oral Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 69. Europe Oral Peptide Therapy Sales by Country (2023-2028) & (Units)
Table 70. Europe Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Oral Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Oral Peptide Therapy Sales by Type (2017-2022) & (Units)
Table 73. Asia Pacific Oral Peptide Therapy Sales by Type (2023-2028) & (Units)
Table 74. Asia Pacific Oral Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Oral Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Oral Peptide Therapy Sales by Application (2017-2022) & (Units)
Table 77. Asia Pacific Oral Peptide Therapy Sales by Application (2023-2028) & (Units)
Table 78. Asia Pacific Oral Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Oral Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Oral Peptide Therapy Sales by Region (2017-2022) & (Units)
Table 81. Asia Pacific Oral Peptide Therapy Sales by Region (2023-2028) & (Units)
Table 82. Asia Pacific Oral Peptide Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Oral Peptide Therapy Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Oral Peptide Therapy Sales by Type (2017-2022) & (Units)
Table 85. Latin America Oral Peptide Therapy Sales by Type (2023-2028) & (Units)
Table 86. Latin America Oral Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Oral Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Oral Peptide Therapy Sales by Application (2017-2022) & (Units)
Table 89. Latin America Oral Peptide Therapy Sales by Application (2023-2028) & (Units)
Table 90. Latin America Oral Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Oral Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 93. Latin America Oral Peptide Therapy Sales by Country (2023-2028) & (Units)
Table 94. Latin America Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Oral Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Oral Peptide Therapy Sales by Type (2017-2022) & (Units)
Table 97. Middle East and Africa Oral Peptide Therapy Sales by Type (2023-2028) & (Units)
Table 98. Middle East and Africa Oral Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Oral Peptide Therapy Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Oral Peptide Therapy Sales by Application (2017-2022) & (Units)
Table 101. Middle East and Africa Oral Peptide Therapy Sales by Application (2023-2028) & (Units)
Table 102. Middle East and Africa Oral Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Oral Peptide Therapy Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 105. Middle East and Africa Oral Peptide Therapy Sales by Country (2023-2028) & (Units)
Table 106. Middle East and Africa Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Oral Peptide Therapy Revenue by Country (2023-2028) & (US$ Million)
Table 108. Allergan Corporation Information
Table 109. Allergan Description and Major Businesses
Table 110. Allergan Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. Allergan Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Allergan Recent Developments
Table 113. Novo Nordisk Corporation Information
Table 114. Novo Nordisk Description and Major Businesses
Table 115. Novo Nordisk Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Novo Nordisk Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novo Nordisk Recent Developments
Table 118. Synergy Pharmaceuticals （Salix） Corporation Information
Table 119. Synergy Pharmaceuticals （Salix） Description and Major Businesses
Table 120. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Synergy Pharmaceuticals （Salix） Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Synergy Pharmaceuticals （Salix） Recent Developments
Table 123. Novartis Corporation Information
Table 124. Novartis Description and Major Businesses
Table 125. Novartis Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Novartis Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Novartis Recent Developments
Table 128. Chiasma Corporation Information
Table 129. Chiasma Description and Major Businesses
Table 130. Chiasma Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Chiasma Oral Peptide Therapy Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Chiasma Recent Developments
Table 133. Key Raw Materials Lists
Table 134. Raw Materials Key Suppliers Lists
Table 135. Oral Peptide Therapy Distributors List
Table 136. Oral Peptide Therapy Customers List
Table 137. Oral Peptide Therapy Market Trends
Table 138. Oral Peptide Therapy Market Drivers
Table 139. Oral Peptide Therapy Market Challenges
Table 140. Oral Peptide Therapy Market Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Peptide Therapy Product Picture
Figure 3. Global Oral Peptide Therapy Market Share by Type in 2021 & 2028
Figure 3. Linaclotide Product Picture
Figure 4. Insulin Product Picture
Figure 5. Plecanatide Product Picture
Figure 6. Cyclosporine Product Picture
Figure 7. Octreotide Product Picture
Figure 8. Global Oral Peptide Therapy Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Oral Peptide Therapy Report Years Considered
Figure 12. Global Oral Peptide Therapy Sales 2017-2028 (Units)
Figure 13. Global Oral Peptide Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Oral Peptide Therapy Revenue 2017-2028 (US$ Million)
Figure 15. Global Oral Peptide Therapy Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Oral Peptide Therapy Sales Market Share by Region (2017-2022)
Figure 17. Global Oral Peptide Therapy Sales Market Share by Region (2023-2028)
Figure 18. North America Oral Peptide Therapy Sales YoY (2017-2028) & (Units)
Figure 19. North America Oral Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Oral Peptide Therapy Sales YoY (2017-2028) & (Units)
Figure 21. Europe Oral Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Oral Peptide Therapy Sales YoY (2017-2028) & (Units)
Figure 23. Asia-Pacific Oral Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Oral Peptide Therapy Sales YoY (2017-2028) & (Units)
Figure 25. Latin America Oral Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Oral Peptide Therapy Sales YoY (2017-2028) & (Units)
Figure 27. Middle East & Africa Oral Peptide Therapy Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Oral Peptide Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Oral Peptide Therapy in the World: Market Share by Oral Peptide Therapy Revenue in 2021
Figure 30. Global Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Oral Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 32. Global Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 33. Global Oral Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 34. Global Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 35. North America Oral Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 36. North America Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 37. North America Oral Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 38. North America Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 39. North America Oral Peptide Therapy Sales Share by Country (2017-2028)
Figure 40. North America Oral Peptide Therapy Revenue Share by Country (2017-2028)
Figure 41. United States Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Oral Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 44. Europe Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 45. Europe Oral Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 46. Europe Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 47. Europe Oral Peptide Therapy Sales Share by Country (2017-2028)
Figure 48. Europe Oral Peptide Therapy Revenue Share by Country (2017-2028)
Figure 49. Germany Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 50. France Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Oral Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Oral Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Oral Peptide Therapy Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Oral Peptide Therapy Revenue Share by Region (2017-2028)
Figure 60. China Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 63. India Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Oral Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 70. Latin America Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Oral Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 72. Latin America Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Oral Peptide Therapy Sales Share by Country (2017-2028)
Figure 74. Latin America Oral Peptide Therapy Revenue Share by Country (2017-2028)
Figure 75. Mexico Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Oral Peptide Therapy Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Oral Peptide Therapy Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Oral Peptide Therapy Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Oral Peptide Therapy Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Oral Peptide Therapy Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Oral Peptide Therapy Revenue Share by Country (2017-2028)
Figure 84. Turkey Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Oral Peptide Therapy Revenue (2017-2028) & (US$ Million)
Figure 87. Oral Peptide Therapy Value Chain
Figure 88. Oral Peptide Therapy Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---